Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Amyotrophic Lateral Sclerosis
100%
Serum Biomarkers
100%
Etiology
18%
Immuno
18%
Patient Samples
9%
Immunoreactivity
9%
Enzyme-linked Immunosorbent Assay (ELISA)
9%
Logistic Regression Analysis
9%
Genetic Studies
9%
Rat Spinal Cord
9%
Serum Samples
9%
Healthy Controls
9%
Thin Layer Chromatography
9%
Neurodegenerative Diseases
9%
Disease Severity
9%
Motor Neuron
9%
Number of Patients
9%
Autoimmune
9%
GD1b
9%
Immunofluorescence Assay
9%
Evaluation Criteria
9%
High Titer
9%
Diagnostic Biomarker
9%
Multiple Causes
9%
Neuronal Cell Lines
9%
Anti-glycolipid Antibody
9%
NSC-34
9%
Motor Neuron Disease
9%
Multifactorial Etiology
9%
Upper Motor Neuron
9%
Lower Motor Neuron
9%
Complex Criterion
9%
Pathogenic Antigen
9%
Amyotrophic Lateral Sclerosis Functional Rating Scale
9%
Immunology and Microbiology
Monospecific Antibody
100%
Thin-Layer Chromatography
75%
Intravenous Immunoglobulin
50%
Mouse
25%
Immunoreactivity
25%
Enzyme-Linked Immunosorbent Assay
25%
Immunofluorescence
25%
Spinal Cord
25%
Titer
25%
Neuronal Cell Line
25%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Paragloboside
100%
Motor Neuron
18%
Intravenous Immunoglobulin
18%
Cell Line
9%
Neurodegenerative Disorder
9%
Immunofluorescence
9%
Glycolipid
9%
Etiology of Amyotrophic Lateral Sclerosis
9%
Upper Motor Neuron
9%
Lower Motor Neuron
9%